Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned

David Weise, Tobias Warnecke, Carsten Buhmann, Georg Ebersbach, Carsten Eggers, Björn Falkenburger, Günter Höglinger, Brit Mollenhauer, David Pedrosa, Martin Südmeyer, Daniel Weiss, Jan Kassubek, Wolfgang H. Jost

Open source

DOI
10.1186/s42466-026-00530-3
Published
2026-08-31
Container
Neurological Research and Practice
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s42466-026-00530-3,
  title = {Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned},
  author = {David Weise and Tobias Warnecke and Carsten Buhmann and Georg Ebersbach and Carsten Eggers and Björn Falkenburger and Günter Höglinger and Brit Mollenhauer and David Pedrosa and Martin Südmeyer and Daniel Weiss and Jan Kassubek and Wolfgang H. Jost},
  year = {2026},
  journal = {Neurological Research and Practice},
  doi = {10.1186/s42466-026-00530-3},
  url = {https://doi.org/10.1186/s42466-026-00530-3}
}

RIS

TY  - JOUR
TI  - Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned
AU  - David Weise
AU  - Tobias Warnecke
AU  - Carsten Buhmann
AU  - Georg Ebersbach
AU  - Carsten Eggers
AU  - Björn Falkenburger
AU  - Günter Höglinger
AU  - Brit Mollenhauer
AU  - David Pedrosa
AU  - Martin Südmeyer
AU  - Daniel Weiss
AU  - Jan Kassubek
AU  - Wolfgang H. Jost
PY  - 2026
JO  - Neurological Research and Practice
DO  - 10.1186/s42466-026-00530-3
UR  - https://doi.org/10.1186/s42466-026-00530-3
ER  - 

APA

Weise, D., Warnecke, T., Buhmann, C., Ebersbach, G., Eggers, C., Falkenburger, B., Höglinger, G., Mollenhauer, B., Pedrosa, D., Südmeyer, M., Weiss, D., Kassubek, J., & Jost, W. H. (2026). Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned. Neurological Research and Practice. https://doi.org/10.1186/s42466-026-00530-3

Source records